Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$CHRD stock is down 10% today. Here's what we see in our data.

None

$CHRD stock has now fallen 10% today, according to our price data from Polygon. There has been approximately $35,384,530 of trading volume.

Here is what we see in our data on $CHRD (you can track the company live on Quiver's $CHRD stock page):

$CHRD Insider Trading Activity

CHRD Insider Trades

$CHRD insiders have traded $CHRD stock on the open market 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $CHRD stock by insiders over the last 6 months:

  • MICHAEL H LOU (EVP, CSO, and CCO) has made 0 purchases and 2 sales selling 15,000 shares for an estimated $1,882,017.
  • RICHARD N ROBUCK (EVP, CFO and Treasurer) sold 5,000 shares for an estimated $608,750
  • LARA J KROLL (SVP & Chief Accounting Officer) sold 5,000 shares for an estimated $568,300
  • DOUGLAS E BROOKS sold 2,126 shares for an estimated $255,715
  • SHANNON BROWNING KINNEY (EVP, CAO, GC & Corp Secretary) sold 1,801 shares for an estimated $205,962
  • SAMANTHA HOLROYD purchased 1,250 shares for an estimated $106,875

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CHRD Hedge Fund Activity

We have seen 173 institutional investors add shares of $CHRD stock to their portfolio, and 262 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CHRD Congressional Stock Trading

Members of Congress have traded $CHRD stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CHRD stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CHRD Analyst Ratings

Wall Street analysts have issued reports on $CHRD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Piper Sandler issued a "Overweight" rating on 01/28/2026
  • UBS issued a "Buy" rating on 01/09/2026
  • Mizuho issued a "Outperform" rating on 12/12/2025
  • William Blair issued a "Outperform" rating on 11/21/2025
  • Wells Fargo issued a "Overweight" rating on 11/14/2025

To track analyst ratings and price targets for $CHRD, check out Quiver Quantitative's $CHRD forecast page.

$CHRD Price Targets

Multiple analysts have issued price targets for $CHRD recently. We have seen 9 analysts offer price targets for $CHRD in the last 6 months, with a median target of $155.0.

Here are some recent targets:

  • Gabe Daoud from Truist Securities set a target price of $187.0 on 04/13/2026
  • Hanwen Chang from Wells Fargo set a target price of $175.0 on 04/08/2026
  • Paul Diamond from Citigroup set a target price of $155.0 on 03/31/2026
  • Devin McDermott from Morgan Stanley set a target price of $168.0 on 03/27/2026
  • Mark Lear from Piper Sandler set a target price of $190.0 on 03/12/2026
  • Josh Silverstein from UBS set a target price of $142.0 on 03/05/2026
  • Scott Hanold from RBC Capital set a target price of $128.0 on 01/13/2026

You can track data on $CHRD on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles